HALOZYME THERAPEUTICS INC (HALO) Stock Fundamental Analysis
USA - NASDAQ:HALO - US40637H1095 - Common Stock
76.345 USD
-0.56 (-0.72%)
Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 540 industry peers in the Biotechnology industry. HALO has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HALO has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make HALO suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
HALO had positive earnings in the past year.
In the past year HALO had a positive cash flow from operations.
Each year in the past 5 years HALO has been profitable.
Each year in the past 5 years HALO had a positive operating cash flow.
1.2 Ratios
HALO's Return On Assets of 27.13% is amongst the best of the industry. HALO outperforms 97.78% of its industry peers.
HALO has a Return On Equity of 167.48%. This is amongst the best in the industry. HALO outperforms 99.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 28.55%, HALO belongs to the top of the industry, outperforming 98.70% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HALO is in line with the industry average of 15.95%.
The 3 year average ROIC (17.81%) for HALO is below the current ROIC(28.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROIC | 28.55% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
With an excellent Profit Margin value of 47.28%, HALO belongs to the best of the industry, outperforming 98.89% of the companies in the same industry.
In the last couple of years the Profit Margin of HALO has declined.
HALO's Operating Margin of 57.92% is amongst the best of the industry. HALO outperforms 99.81% of its industry peers.
In the last couple of years the Operating Margin of HALO has declined.
Looking at the Gross Margin, with a value of 84.20%, HALO belongs to the top of the industry, outperforming 87.22% of the companies in the same industry.
In the last couple of years the Gross Margin of HALO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% |
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HALO is creating value.
The number of shares outstanding for HALO has been reduced compared to 1 year ago.
The number of shares outstanding for HALO has been reduced compared to 5 years ago.
Compared to 1 year ago, HALO has an improved debt to assets ratio.
2.2 Solvency
HALO has an Altman-Z score of 5.63. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
HALO has a Altman-Z score of 5.63. This is in the better half of the industry: HALO outperforms 77.04% of its industry peers.
HALO has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as HALO would need 2.79 years to pay back of all of its debts.
The Debt to FCF ratio of HALO (2.79) is better than 94.07% of its industry peers.
A Debt/Equity ratio of 4.54 is on the high side and indicates that HALO has dependencies on debt financing.
With a Debt to Equity ratio value of 4.54, HALO is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Altman-Z | 5.63 |
ROIC/WACC3.2
WACC8.93%
2.3 Liquidity
A Current Ratio of 8.36 indicates that HALO has no problem at all paying its short term obligations.
HALO has a Current ratio of 8.36. This is in the better half of the industry: HALO outperforms 74.81% of its industry peers.
A Quick Ratio of 7.01 indicates that HALO has no problem at all paying its short term obligations.
HALO's Quick ratio of 7.01 is fine compared to the rest of the industry. HALO outperforms 69.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 |
3. Growth
3.1 Past
HALO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.41%, which is quite impressive.
HALO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.12% yearly.
Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 34.97%.
The Revenue has been growing by 38.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
3.2 Future
Based on estimates for the next years, HALO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.63% on average per year.
Based on estimates for the next years, HALO will show a quite strong growth in Revenue. The Revenue will grow by 12.63% on average per year.
EPS Next Y47.96%
EPS Next 2Y38.15%
EPS Next 3Y32.51%
EPS Next 5Y17.63%
Revenue Next Year31.57%
Revenue Next 2Y27.35%
Revenue Next 3Y23.97%
Revenue Next 5Y12.63%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.74, which indicates a correct valuation of HALO.
Compared to the rest of the industry, the Price/Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 95.37% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, HALO is valued a bit cheaper.
A Price/Forward Earnings ratio of 9.46 indicates a reasonable valuation of HALO.
HALO's Price/Forward Earnings ratio is rather cheap when compared to the industry. HALO is cheaper than 97.22% of the companies in the same industry.
HALO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.73.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.74 | ||
| Fwd PE | 9.46 |
4.2 Price Multiples
HALO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HALO is cheaper than 95.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HALO is valued cheaper than 95.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.52 | ||
| EV/EBITDA | 12.39 |
4.3 Compensation for Growth
HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HALO has an outstanding profitability rating, which may justify a higher PE ratio.
HALO's earnings are expected to grow with 32.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y38.15%
EPS Next 3Y32.51%
5. Dividend
5.1 Amount
No dividends for HALO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HALO (9/15/2025, 2:51:58 PM)
76.345
-0.56 (-0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners100.38%
Inst Owner Change5.29%
Ins Owners0.82%
Ins Owner Change0.1%
Market Cap8.93B
Analysts75
Price Target72.93 (-4.47%)
Short Float %9.15%
Short Ratio4.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.03%
Min EPS beat(2)14.79%
Max EPS beat(2)19.26%
EPS beat(4)4
Avg EPS beat(4)16.87%
Min EPS beat(4)6.64%
Max EPS beat(4)26.79%
EPS beat(8)7
Avg EPS beat(8)12.25%
EPS beat(12)10
Avg EPS beat(12)12.69%
EPS beat(16)13
Avg EPS beat(16)10.59%
Revenue beat(2)2
Avg Revenue beat(2)12.25%
Min Revenue beat(2)11.69%
Max Revenue beat(2)12.81%
Revenue beat(4)4
Avg Revenue beat(4)9.78%
Min Revenue beat(4)1.36%
Max Revenue beat(4)13.28%
Revenue beat(8)5
Avg Revenue beat(8)5.19%
Revenue beat(12)7
Avg Revenue beat(12)3.36%
Revenue beat(16)9
Avg Revenue beat(16)2.8%
PT rev (1m)7.32%
PT rev (3m)1.32%
EPS NQ rev (1m)0.6%
EPS NQ rev (3m)11.57%
EPS NY rev (1m)11.56%
EPS NY rev (3m)17.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.16%
Revenue NY rev (1m)5.73%
Revenue NY rev (3m)5.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.74 | ||
| Fwd PE | 9.46 | ||
| P/S | 7.58 | ||
| P/FCF | 16.52 | ||
| P/OCF | 16.3 | ||
| P/B | 26.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.39 |
EPS(TTM)5.18
EY6.78%
EPS(NY)8.07
Fwd EY10.57%
FCF(TTM)4.62
FCFY6.05%
OCF(TTM)4.68
OCFY6.13%
SpS10.08
BVpS2.84
TBVpS-3.85
PEG (NY)0.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 27.13% | ||
| ROE | 167.48% | ||
| ROCE | 35.56% | ||
| ROIC | 28.55% | ||
| ROICexc | 39.96% | ||
| ROICexgc | 93.15% | ||
| OM | 57.92% | ||
| PM (TTM) | 47.28% | ||
| GM | 84.2% | ||
| FCFM | 45.87% |
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
ROICexc(3y)23.94%
ROICexc(5y)N/A
ROICexgc(3y)71.73%
ROICexgc(5y)N/A
ROCE(3y)22.19%
ROCE(5y)37.11%
ROICexcg growth 3Y-1.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-28.16%
ROICexc growth 5YN/A
OM growth 3Y-4.44%
OM growth 5YN/A
PM growth 3Y-21.62%
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y1.9%
F-Score8
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.54 | ||
| Debt/FCF | 2.79 | ||
| Debt/EBITDA | 1.97 | ||
| Cap/Depr | 8.67% | ||
| Cap/Sales | 0.6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.66% | ||
| Profit Quality | 97.02% | ||
| Current Ratio | 8.36 | ||
| Quick Ratio | 7.01 | ||
| Altman-Z | 5.63 |
F-Score8
WACC8.93%
ROIC/WACC3.2
Cap/Depr(3y)13.62%
Cap/Depr(5y)33.32%
Cap/Sales(3y)1.21%
Cap/Sales(5y)0.98%
Profit Quality(3y)118.15%
Profit Quality(5y)93.9%
High Growth Momentum
Growth
EPS 1Y (TTM)58.41%
EPS 3Y30.12%
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y47.96%
EPS Next 2Y38.15%
EPS Next 3Y32.51%
EPS Next 5Y17.63%
Revenue 1Y (TTM)34.97%
Revenue growth 3Y31.82%
Revenue growth 5Y38.95%
Sales Q2Q%40.79%
Revenue Next Year31.57%
Revenue Next 2Y27.35%
Revenue Next 3Y23.97%
Revenue Next 5Y12.63%
EBIT growth 1Y68.72%
EBIT growth 3Y25.97%
EBIT growth 5YN/A
EBIT Next Year48.84%
EBIT Next 3Y31.32%
EBIT Next 5Y15.57%
FCF growth 1Y84.66%
FCF growth 3Y16.28%
FCF growth 5YN/A
OCF growth 1Y79.07%
OCF growth 3Y16.96%
OCF growth 5YN/A